TriSalus Life Sciences (TLSI) Non-Current Debt (2023 - 2026)
TriSalus Life Sciences (TLSI) posted quarterly Non-Current Debt of $33.1 million for Q1 2026, up 4.35% year-over-year from $31.7 million in Q1 2025, and little changed quarter-over-quarter from $33.0 million in Q4 2025.
TriSalus Life Sciences (TLSI) Non-Current Debt (2023 - 2026) Analysis & Trends
TriSalus Life Sciences' Non-Current Debt history runs 4 years deep, the most recent figure standing at $33.1 million for Q1 2026.
- In Q1 2026, Non-Current Debt rose 4.35% year-over-year to $33.1 million; the TTM figure through Mar 2026 stood at $33.1 million (up 4.35% YoY), while the FY2025 annual figure was $33.0 million, up 49.64% from the prior year.
- Non-Current Debt for Q1 2026 stood at $33.1 million, roughly flat from $33.0 million in the prior quarter.
- The five-year high for Non-Current Debt was $33.1 million in Q1 2026, with the low at $629222.0 in Q2 2023.
- The 4-year median for Non-Current Debt is $31.7 million (2025), against an average of $25.4 million.
- The sharpest annual moves came in 2024 and 2026: Non-Current Debt soared 3282.91% in 2024, then grew 4.35% in 2026.
- TriSalus Life Sciences' Non-Current Debt stood at $629222.0 in 2023, then surged by 3409.73% to $22.1 million in 2024, then soared by 49.64% to $33.0 million in 2025, then advanced by 0.1% to $33.1 million in 2026.
- Business Quant data shows TLSI's Non-Current Debt at $33.1 million in Q1 2026, $33.0 million in Q4 2025, and $32.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.62 Bn | 197.02 Bn | 7.27 Bn | 29.60 Bn |
| 2 | Stryker | 127.01 Bn | 123.54 Bn | 4.50 Bn | 14.19 Bn |
| 3 | Medtronic | 119.39 Bn | 110.17 Bn | 6.41 Bn | 26.17 Bn |
| 4 | Boston Scientific | 74.56 Bn | 74.02 Bn | 3.85 Bn | 10.92 Bn |
| 5 | Edwards Lifesciences | 51.82 Bn | 47.57 Bn | 1.35 Bn | 598.70 Mn |
| 6 | Dexcom | 34.98 Bn | 33.03 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.85 Bn | 31.74 Bn | 2.18 Bn | 10.09 Bn |
| 8 | Koninklijke Philips | 26.26 Bn | 22.94 Bn | 4.55 Bn | 7.34 Bn |
| 9 | Steris | 23.23 Bn | 22.75 Bn | 684.20 Mn | 1.65 Bn |
| 10 | TriSalus Life Sciences | 310.72 Mn | 264.43 Mn | 9.90 Mn | 33.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 33.07 Mn |
| Mar 31, 2026 | 33.08 Mn |
| Dec 31, 2025 | 33.05 Mn |
| Sep 30, 2025 | 32.76 Mn |
| Jun 30, 2025 | 32.27 Mn |
| Mar 31, 2025 | 31.70 Mn |
| Dec 31, 2024 | 22.08 Mn |
| Sep 30, 2024 | 21.68 Mn |
| Jun 30, 2024 | 21.29 Mn |
| Jun 30, 2023 | 629,222.00 |